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Abstract
Several studies have underlined the high prevalence of psychiatric symptoms
and disorders in thyroid diseases. The aim of this study was to evaluate the
prevalence of psychiatric disorders in 93 inpatients affected by different thy-
roid diseases during their lifetimes, by means of a standardized instrument,
i.e., the Structured Clinical Interview for Diagnostic and Statistical Manual of
Mental Disorders-III-Revised, Upjohn Version (SCID-UP-R). The results
showed higher rates of panic disorder, simple phobia, obsessive-compulsive
disorder, major depressive disorder, bipolar disorder and cyclothymia in thy-
roid patients than in the general population. These findings would suggest that
the co-occurrence of psychiatric and thyroid diseases may be the result of com-
mon biochemical abnormalities.
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Introduction
The first descriptions of neuropsychiatric symptoms,
in particular impairments of cognitive functions, behav-
ioral and mood disturbances, increased or decreased ap-
petite and motor activity, muscular weakness and tremors
and palpitations in patients with thyroid diseases, date
back to the 19th century [1, 2]. Subsequently, they were
documented by different authors [3–9] and mainly inter-
preted as consequences of thyroid dysfunctions and,
therefore, subject to improvement after specific treat-
ments for thyroid. 
Anxiety states with symptoms similar to those of panic
disorder, have been observed in hyperthyroidism [1, 2].
Subjects with thyroid diseases and a positive family histo-
ry of mood disorders [10, 11] have also been reported as
suffering from mania and hypomania, depression, obses-
sive compulsive symptoms and organic mental disorders,
such as delirium [12, 13]. 
Depression and impairment of attention and memory
seem to be more common in hypothyroidism [14], while
depression, paranoid ideation and auditory or visual hal-
lucinations are more typical of acute conditions such as
mixedema [15]. 
Recently, more attention has been devoted to the diag-
nostic assessment of mental disorders concomitant with
thyroid diseases, the more frequently reported diagnoses
being schizophrenia, anxiety states, mood disorders and
paranoid syndromes [16–18]. Furthermore, some authors
underline the problem of distinguishing thyrotoxicosis
from panic disorder or generalized anxiety disorder, espe-
cially in the early stages of the disorder [19, 20]. 
Less information is available on the possible relation-
ship between autoimmune thyroid disorders and psy-
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chiatric disorders: according to some authors, dysregula-
tions in some components of the immune response may
themselves produce abnormal behaviors, even in ‘euthy-
roid’ states [20–22]. Furthermore, the available studies in
this field are limited to the evaluation of the psychiatric
symptoms that are concomitant with the thyroid disease,
without taking into consideration the familial or personal
history of the individual. 
Our study aimed, therefore, at evaluating the frequen-
cy and severity of anxiety and mood disorders during the
lifetime of patients with Graves’ disease. Patients with
other thyroid diseases were also included for further com-
parisons.
Method
Ninety-three inpatients (72 female, 21 male, aged between 21 and
81 years, mean B SD 48.2 B 13.7) consecutively recruited at the
Endocrinology Department of Pisa University, were studied. The
endocrinologists (E.F., L.C.) reviewed all thyroid function test abnor-
malities and classified the patients being treated in a naturalistic way:
47 (38 female, 9 male) were affected by Graves’ disease, 30 (24
female, 6 male) by multinodular goiter, 10 (6 female, 4 male) by ade-
noma, 5 (3 female, 2 male) by thyroid cancer and 1 (female) by phar-
macological hyperthyroidism (table 1). 
The presence of psychiatric disorders was assessed by means of
the Structured Clinical Interview for DSM-III-R Upjohn Version
(SCID-UP-R [23]) for Anxiety and Mood Disorder, by two residents
of the Institute of Psychiatry of Pisa University, each with at least
4 years of clinical experience, under the supervision of senior psy-
chiatrists. Subjects were also interviewed according to the Akiskal
and Mallya criteria for affective temperaments [24].
Statistical analyses
The data were loaded into a database and statistically analyzed by
means of frequency distribution. Comparisons between groups on
continuous variables were carried out using Student’s t test and on
categorical variables, using ¯2 analysis. To minimize the chance of
type II errors with the multiple comparisons, the Bonferroni correc-
tion was used to calculate the level of probability considered statisti-
cally significant. Only those variables with a value of p ! 0.05 were
considered statistically significant. However, variables significant at
p ! 0.01 are also shown in the tables as representing a trend deserving
attention.
Results
The percentage of patients with psychiatric diagnoses,
out of the total of 93 thyroid patients, was 63.2% (n = 68).
Panic disorder (PD) was the most commonly reported dis-
order (45.6%, n = 31), followed by generalized anxiety dis-
order (GAD) (41.2%, n = 28), past depressive episodes
(32.4%,; n = 22), simple phobia (SP) (17.9%, n = 12),
Table 1. Demographic features and thyroid diseases of the
patients (72 females, 21 males)
Mean B SD
Age 48.2B13.7 
features Age at onset (thyroid disease) 41.1B14.1 
Duration of thyroid disease,
months 52.0B35.5
Thyroid diseases Graves’ disease 47 (38 f, 9 m) 
Multinodular goiter 30 (24 f, 6 m)
Adenoma 10 (6 f, 4 m) 
Thyroid cancer 5 (3 f, 2 m) 
Iatrogenic hyperthyroidism 1 (f)
Table 2. Psychiatric disorder in 68 out of 93 patients with thyroid
diseases
Psychiatric disorder n %
31 (26 f, 5 m) 45.6 
Generalized anxiety disorder 28 (27 f, 1 m) 41.2 
Major depressive episode (past) 22 (21 f,1 m) 32.4 
Simple phobia 12 (12 f, 0 m) 17.6 
Obsessive compulsive disorder 5 (f) 7.4 
Social phobia 5 (f) 7.4 
Manic episode (past) 4 (f) 5.9 
Major depressive episode (current) 3 (f) 4.4 
Cyclothymia 2 (f) 2.9
Substance abuse 1 (f) 1.5
Comparison between females and males (only significant data are
reported) SP: ¯2 = 4.019, p = 0.045; GAD: ¯2 = 6.798, p = 0.004,
past MDE: ¯ 2 = 4.096, p = 0.043.
social phobia and obsessive compulsive disorder (OCD)
(7.4%, n = 5), current major depressive episodes (MDE)
(4.4%, n = 3). A positive past history for a manic episode
was found in 5.9% (n = 4) of the patients, cyclothymia in
2.9% (n = 2) and substance abuse in 1.5% (n = 1) (table 2).
Most of the 68 patients had two or more psychiatric diag-
noses: 14 (20.6%) patients had two diagnoses, 9 (13.2%)
patients three, 5 (7.4%) patients four and 1 (1.5%) patient
five diagnoses. 
Significant differences between males and females
were observed for SP (12 female, 0 male; ¯2 = 4.019, p =
0.045), GAD (27 female, 1 male; ¯2 = 6.798, p = 0.009),
and MDE in the past (21 female, 1 male; ¯2 = 4.096, p =
0.043 ). No difference between the autoimmune and non-
autoimmune diseases was recorded except a trend for
Panic disorder
Depressive
224 Neuropsychobiology 1998;38:222–225 Placidi/Boldrini/Patronelli/Fiore/Chiovato/
Perugi/Marazziti
Table 3.  Psychiatric disorders in 93 patients with thyroid dis-
ease: autoimmune vs. nonautoimmune
Psychiatric disorder Graves’ disease
(n = 47)
n %
Others
(n = 46)
n %
17 36.1 14 30.4
Generalized anxiety disorder 15 31.9 13 28.3
Major depressive episode (past) 11 23.4 11 23.9
Simple phobia 10 21.3 2 4.3
Obsessive compulsive disorder 5 10.6 0 0 
Social phobia 4 8.5 1 2.2
Major depressive episode 3 6.4 0 0 
Manic episode 2 4.3 4.3 2 
Cyclothymia 2 4.3 0 0 
Substance abuse 0 0 1 2.2
Table 4.  Affective temperament in 93
patients with thyroid disease
Temperament n %
30 27.9 
Hyperthymic 7 6.51 
Cyclothymic 7 6.51 
Irritable 3 2.8
OCD (¯2 = 6.32; p = 0.0119) and SP (¯2 = 5.172; p = 0.023)
being more common in Graves’ disease (table 3).
With regard to affective temperament, a depressive
temperament was observed in 27.9% (n = 30), a hyper-
thymic temperament in 6.51% (n = 7), a cyclothymic tem-
perament in 6.51% (n = 7) and an irritable temperament
in 2.8% (n = 3) of subjects (table 4).
Discussion
The results of our study showed that a number of
patients affected by different thyroid diseases were suffer-
ing concomitantly from a major psychiatric disorder. The
most frequently encountered was PD, followed by GAD,
MDE, SP and OCD. The prevalence rate was significantly
higher than that reported in the USA by Regier and
Robins [25] and in Italy by Bellantuono et al. [26]. The
comorbidity between PD and thyroid diseases, especially
hyperthyroidism, has already been underlined [27–29].
In our sample, MDEs and manic episodes were mainly
recorded in the past; this is in contrast with previous stud-
ies which have reported a high incidence of depressive
symptoms in thyroid diseases. However, our study is one
of the few employing a semistructured interview which
takes into account not only the current, thyroid disease-
related psychiatric symptoms, but also those present dur-
ing the subjects’ lifetime. 
When the patients were analyzed according to sex, sig-
nificant differences between males and females emerged:
female patients, who outnumbered the males 3:1 times in
the total sample (not surprisingly, since thyroid diseases
are more prevalent in females), showed a significantly
higher percentage of GAD (27 vs. 1), MDE in the past (21
vs. 1) and SP (12 vs. 0); this would suggest the possible
existence of sex-related patterns of psychiatric disorders
in patients with thyroid diseases.
On the other hand, no difference was observed be-
tween patients with and without autoimmune thyroid dis-
eases; however, although some diseases were present in an
insufficient number of subjects for a reliable statistical
analysis to be carried out, there was a trend for OCD and
SP to be more common in Graves’ disease. 
The presence of psychiatric disorders during the life-
time of thyroid diseased patients would indicate that they
are not related only to the occurrence of a physical illness,
or to a sudden alteration in hormone levels or to specific
thyroid treatments [30–32], but rather to persistent neu-
rochemical abnormalities, perhaps at the level of a generic
vulnerability to psychopathology, that may be restricted
to temperament pathology or may trigger ‘full’ psychiatric
disorders. 
Alternatively, both thyroid diseases and psychiatric
disorders might be the expression of a common dysfunc-
tion yet to be identified, perhaps affecting the hypothala-
mus or at the level of interactions between the immune
and the central nervous systems.
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